Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $70.22.
Several brokerages recently issued reports on ACHC. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Royal Bank of Canada reiterated an “outperform” rating and issued a $64.00 target price on shares of Acadia Healthcare in a research note on Friday, January 10th. TD Cowen cut their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the company from $45.00 to $75.00 in a report on Thursday, December 12th.
Get Our Latest Analysis on Acadia Healthcare
Institutional Inflows and Outflows
Acadia Healthcare Trading Down 0.4 %
Shares of NASDAQ:ACHC opened at $40.94 on Friday. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The company has a market capitalization of $3.80 billion, a P/E ratio of 13.42, a price-to-earnings-growth ratio of 1.51 and a beta of 1.30. The company has a 50-day simple moving average of $42.14 and a 200 day simple moving average of $53.36. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- Why Invest in High-Yield Dividend Stocks?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Insider Trading – What You Need to Know
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.